相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Features Associated with Survival in Metastatic Melanoma Patients Treated with Patient-Specific Dendritic Cell Vaccines
Robert O. Dillman et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2011)
Coactivation of AKT and β-Catenin in Mice Rapidly Induces Formation of Lipogenic Liver Tumors
Jimmy K. Stauffer et al.
CANCER RESEARCH (2011)
A methodological framework to enhance the clinical success of cancer immunotherapy
Axel Hoos et al.
NATURE BIOTECHNOLOGY (2011)
Integrated NY-ESO-1 antibody and CD8+ T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
Jianda Yuan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2011)
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
Padmanee Sharma et al.
NATURE REVIEWS CANCER (2011)
Assessing oncologic benefit in clinical trials of immunotherapy agents
R. K. Hales et al.
ANNALS OF ONCOLOGY (2010)
New models for cancer research: human cancer stem cell xenografts
Marta Baiocchi et al.
CURRENT OPINION IN PHARMACOLOGY (2010)
Improved Endpoints for Cancer Immunotherapy Trials
Axel Hoos et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2010)
Improved Survival with Ipilimumab in Patients with Metastatic Melanoma
F. Stephen Hodi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Melanoma from bench to bedside: meeting report from the 6th international melanoma congress
D. E. Fisher et al.
Pigment Cell & Melanoma Research (2010)
A critical analysis of the tumour immunosurveillance controversy for 3-MCA-induced sarcomas
T. H. Schreiber et al.
BRITISH JOURNAL OF CANCER (2009)
Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium
Cedrik Michael Britten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
Cancer Pharmacoethnicity: Ethnic Differences in Susceptibility to the Effects of Chemotherapy
Peter H. O'Donnell et al.
CLINICAL CANCER RESEARCH (2009)
Guidelines for the Evaluation of Immune Therapy Activity in Solid Tumors: Immune-Related Response Criteria
Jedd D. Wolchok et al.
CLINICAL CANCER RESEARCH (2009)
Immunogenicity and Antitumor Effects of Vaccination with Peptide Vaccine +/- Granulocyte-Monocyte Colony-Stimulating Factor and/or IFN-α2b in Advanced Metastatic Melanoma: Eastern Cooperative Oncology Group Phase II Trial E1696
John M. Kirkwood et al.
CLINICAL CANCER RESEARCH (2009)
MIATA-Minimal Information about T Cell Assays
Sylvia Janetzki et al.
IMMUNITY (2009)
Immunotherapeutics in Development for Prostate Cancer
Andrea L. Harzstark et al.
ONCOLOGIST (2009)
Translational research working group developmental pathway for immune response modifiers
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2008)
Twelve immunotherapy drugs that could cure cancers
Martin A. ‘Mac’ Cheever
IMMUNOLOGICAL REVIEWS (2008)
The anticancer immune response: indispensable for therapeutic success?
Laurence Zitvogel et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
A systematic approach to biomarker discovery; Preamble to the iSBTc-FDA taskforce on immunotherapy biomarkers
Lisa H. Butterfield et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2008)
Stromal gene expression predicts clinical outcome in breast cancer
Greg Finak et al.
NATURE MEDICINE (2008)
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients
F. Stephen Hodi et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
CTLA-4 blockade increases IFNγ-producing CD4+ICOShi cells to shift the ratio of effector to regulatory T cells in cancer patients
Chrysoula I. Liakou et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
The CIMT-monitoring panel:: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays
C. M. Britten et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Adaptive immunity maintains occult cancer in an equilibrium state
Catherine M. Koebel et al.
NATURE (2007)
Sensors of ionizing radiation effects on the immunological microenvironment of cancer
Sandra Demaria et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2007)
A clinical development paradigm for cancer vaccines and related biologics
Axel Hoos et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Development of functional human blood and immune systems in NOD/SCID/IL2 receptor γ chainnull mice
F Ishikawa et al.
BLOOD (2005)
Opinion - Immunotherapy and chemotherapy - a practical partnership
RA Lake et al.
NATURE REVIEWS CANCER (2005)
Contrasting frequencies of antitumor and anti-vaccine T cells in metastases of a melanoma patient vaccinated with a MAGE tumor antigen
C Lurquin et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Cancer regression and autoimmunity induced by cytotoxic T lymphocyte-associated antigen 4 blockade in patients with metastatic melanoma
GQ Phan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
SCID mouse models to study human cancer pathogenesis and approaches to therapy: Potential, limitations, and future directions
RB Bankert et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
SCID mouse models to study human cancer pathogenesis and approaches to therapy: Potential, limitations, and future directions
RB Bankert et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2002)
分享论文
